A composite measure of sleep health is associated with symptoms of depression among Japanese female hospital nurses.


Journal

Comprehensive psychiatry
ISSN: 1532-8384
Titre abrégé: Compr Psychiatry
Pays: United States
ID NLM: 0372612

Informations de publication

Date de publication:
02 2020
Historique:
received: 26 07 2019
revised: 04 11 2019
accepted: 29 11 2019
pubmed: 19 1 2020
medline: 21 10 2020
entrez: 19 1 2020
Statut: ppublish

Résumé

Individual dimensions of sleep health, including satisfaction, sleepiness/alertness, timing, efficiency, and duration, are associated with depression. We investigated whether a composite sleep health score is associated with symptoms of depression among Japanese female hospital nurses. Participants were nurses (n = 2482, all women, age 31.2 ± 8.9 years) working at three general hospitals in Tokyo, Japan. A cross-sectional survey, conducted in 2015, assessed self-reported sleep and symptoms of depression. Sleep health was categorized as "good" or "poor" across five dimensions: satisfaction, daytime sleepiness, mid-sleep time, efficiency, and duration. A composite sleep health score was calculated by summing the number of "poor" dimensions. Depression was defined by depressed mood, loss of interest, or at least one of those symptoms ("depression symptoms"). Associations between sleep health and symptoms of depression were evaluated with multivariate logistic regression analyses, adjusting for sociodemographic factors and hypnotic medication use. In multivariate logistic regression analyses, sleep health symptoms of poor satisfaction, efficiency, and duration were significantly associated with depressed mood; daytime sleepiness and poor efficiency were significantly associated with loss of interest; and poor satisfaction, daytime sleepiness, mid-sleep time, and efficiency were significantly associated with having at least one depressive symptom. The composite sleep health score was associated in a graded fashion with greater odds of depression symptoms. Individual and composite sleep health scores were associated with symptoms of depression. Assessing composite measures of multidimensional sleep health may help to better understand the well-known associations between poor sleep and depression and lead to improved intervention strategies.

Sections du résumé

BACKGROUND
Individual dimensions of sleep health, including satisfaction, sleepiness/alertness, timing, efficiency, and duration, are associated with depression. We investigated whether a composite sleep health score is associated with symptoms of depression among Japanese female hospital nurses.
METHODS
Participants were nurses (n = 2482, all women, age 31.2 ± 8.9 years) working at three general hospitals in Tokyo, Japan. A cross-sectional survey, conducted in 2015, assessed self-reported sleep and symptoms of depression. Sleep health was categorized as "good" or "poor" across five dimensions: satisfaction, daytime sleepiness, mid-sleep time, efficiency, and duration. A composite sleep health score was calculated by summing the number of "poor" dimensions. Depression was defined by depressed mood, loss of interest, or at least one of those symptoms ("depression symptoms"). Associations between sleep health and symptoms of depression were evaluated with multivariate logistic regression analyses, adjusting for sociodemographic factors and hypnotic medication use.
RESULTS
In multivariate logistic regression analyses, sleep health symptoms of poor satisfaction, efficiency, and duration were significantly associated with depressed mood; daytime sleepiness and poor efficiency were significantly associated with loss of interest; and poor satisfaction, daytime sleepiness, mid-sleep time, and efficiency were significantly associated with having at least one depressive symptom. The composite sleep health score was associated in a graded fashion with greater odds of depression symptoms.
CONCLUSION
Individual and composite sleep health scores were associated with symptoms of depression. Assessing composite measures of multidimensional sleep health may help to better understand the well-known associations between poor sleep and depression and lead to improved intervention strategies.

Identifiants

pubmed: 31954287
pii: S0010-440X(19)30074-4
doi: 10.1016/j.comppsych.2019.152151
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

152151

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Dr. Uchiyama reports that his department received research support from: Astellas Pharma, Eisai, Meijiseika Pharma, Mochida Pharmaceutical, MSD, Pfizer, Sanofi, Takeda Pharmaceutical, and Yoshitomiyakuhin Corporation. He has provided consulting services to Janssen Pharma, Kao, Shionogi & Co., Taisho Pharmaceutical and Takeda Pharmaceutical. Dr. Buysse has served as a paid consultant for Bayer, Ebb Therapeutics, Weight Watchers, BeHealth Solutions, Emmi Solutions. He has contributed to educational products or presentations funded by Eisai, CME Institute, and the American Academy of Physician Assistants. Dr. Kaneita reports that his department received research support from Eisai Co., Ltd. Dr. Buysse receives licensing fees for the Pittsburgh Sleep Quality Index, Insomnia Symptoms Questionnaire, Daytime Insomnia Symptom Scale, and Consensus Sleep Diary.

Auteurs

Ryuji Furihata (R)

Department of Psychiatry, Nihon University School of Medicine, Tokyo, Japan.

Kaori Saitoh (K)

Department of Psychiatry, Nihon University School of Medicine, Tokyo, Japan.

Masahiro Suzuki (M)

Department of Psychiatry, Nihon University School of Medicine, Tokyo, Japan.

Maki Jike (M)

Division of Public Health, Department of Social Medicine, Nihon University School of Medicine, Tokyo, Japan; Department of Food Safety and Management, Faculty of Life and Environmental Sciences, Showa Women's University, Tokyo, Japan.

Yoshitaka Kaneita (Y)

Division of Public Health, Department of Social Medicine, Nihon University School of Medicine, Tokyo, Japan.

Takashi Ohida (T)

Division of Public Health, Department of Social Medicine, Nihon University School of Medicine, Tokyo, Japan.

Daniel J Buysse (DJ)

Sleep and Chronobiology Center, Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

Makoto Uchiyama (M)

Department of Psychiatry, Nihon University School of Medicine, Tokyo, Japan. Electronic address: uchiyama.makoto@nihon-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH